JP2007500716A5 - - Google Patents

Download PDF

Info

Publication number
JP2007500716A5
JP2007500716A5 JP2006522073A JP2006522073A JP2007500716A5 JP 2007500716 A5 JP2007500716 A5 JP 2007500716A5 JP 2006522073 A JP2006522073 A JP 2006522073A JP 2006522073 A JP2006522073 A JP 2006522073A JP 2007500716 A5 JP2007500716 A5 JP 2007500716A5
Authority
JP
Japan
Prior art keywords
alkyl
group
hydrogen
cycloalkyl
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006522073A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007500716A (ja
JP4884219B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/024542 external-priority patent/WO2005011654A2/en
Publication of JP2007500716A publication Critical patent/JP2007500716A/ja
Publication of JP2007500716A5 publication Critical patent/JP2007500716A5/ja
Application granted granted Critical
Publication of JP4884219B2 publication Critical patent/JP4884219B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006522073A 2003-07-29 2004-07-29 ピリジル誘導体および治療剤としてのその用途 Expired - Fee Related JP4884219B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US49114003P 2003-07-29 2003-07-29
US60/491,140 2003-07-29
US49108003P 2003-07-30 2003-07-30
US49132203P 2003-07-30 2003-07-30
US49114103P 2003-07-30 2003-07-30
US49111603P 2003-07-30 2003-07-30
US60/491,141 2003-07-30
US60/491,116 2003-07-30
US60/491,322 2003-07-30
US60/491,080 2003-07-30
PCT/US2004/024542 WO2005011654A2 (en) 2003-07-29 2004-07-29 Pyridyl derivatives and their use as therapeutic agents

Publications (3)

Publication Number Publication Date
JP2007500716A JP2007500716A (ja) 2007-01-18
JP2007500716A5 true JP2007500716A5 (enExample) 2007-09-13
JP4884219B2 JP4884219B2 (ja) 2012-02-29

Family

ID=34120125

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006522073A Expired - Fee Related JP4884219B2 (ja) 2003-07-29 2004-07-29 ピリジル誘導体および治療剤としてのその用途

Country Status (17)

Country Link
US (3) US7763618B2 (enExample)
EP (1) EP1651605B1 (enExample)
JP (1) JP4884219B2 (enExample)
KR (1) KR20060036105A (enExample)
AT (1) ATE556056T1 (enExample)
AU (1) AU2004261250B2 (enExample)
BR (1) BRPI0413059A (enExample)
CA (1) CA2533898A1 (enExample)
EC (1) ECSP066314A (enExample)
ES (1) ES2386354T3 (enExample)
IL (1) IL173397A0 (enExample)
MA (1) MA28012A1 (enExample)
MX (1) MXPA06001202A (enExample)
NO (1) NO20060973L (enExample)
SG (1) SG145695A1 (enExample)
TN (1) TNSN06035A1 (enExample)
WO (1) WO2005011654A2 (enExample)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517884B2 (en) 1998-03-30 2009-04-14 Kalypsys Inc. Sulfonyl-substituted bicyclic compounds as modulators of PPAR
DE602004021206D1 (de) * 2003-07-24 2009-07-02 Euro Celtique Sa Zur Behandlung oder Vorbeugung von Schmerzen geeignete Heteroaryl-Tetrahydropiperidyl-Verbindungen
CA2533898A1 (en) 2003-07-29 2005-02-10 Xenon Pharmaceuticals Inc. Pyridyl derivatives and their use as therapeutic agents
AU2004261267B9 (en) * 2003-07-30 2009-04-09 Xenon Pharmaceuticals Inc. Pyridyl derivatives and their use as therapeutic agents
WO2006101521A2 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP2316458A1 (en) 2004-09-20 2011-05-04 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
AR051026A1 (es) 2004-09-20 2006-12-13 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
AU2005286846A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
BRPI0515499A (pt) * 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados de piridina para a inibição de estearoil-coa-desaturase humana
AU2005286647A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
BRPI0515477A (pt) * 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos bicìclicos e o uso dos mesmos como inibidores de estaroil-coa-desaturase (scd)
US8071603B2 (en) 2004-09-20 2011-12-06 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
US7951805B2 (en) 2004-09-20 2011-05-31 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
BRPI0516435B1 (pt) 2004-10-29 2021-09-21 Kalypsys , Inc Composto, e composição farmacêutica
ATE466842T1 (de) * 2004-12-03 2010-05-15 Hoffmann La Roche 3-substituierte pyridinderivate als h3- antagonisten
EP1828134B1 (en) * 2004-12-16 2008-10-29 F.Hoffmann-La Roche Ag Piperazinyl pyridine derivatives as anti-obesity agents
US7750011B2 (en) 2005-02-15 2010-07-06 Neurosearch A/S Diazabicyclic aryl derivatives and their medical use
WO2006125194A2 (en) * 2005-05-19 2006-11-23 Xenon Pharmaceuticals Inc. Piperazine derivatives and their uses as therapeutic agents
WO2006125179A1 (en) * 2005-05-19 2006-11-23 Xenon Pharmaceuticals Inc. Tricyclic compounds and their uses as therapeutic agents
WO2006125180A1 (en) * 2005-05-19 2006-11-23 Xenon Pharmaceuticals Inc. Piperazine derivatives and their uses as therapeutic agents
JP2009513563A (ja) 2005-06-03 2009-04-02 ゼノン・ファーマシューティカルズ・インコーポレイテッド ヒトのステアロイル−ＣｏＡデサチュラーゼ阻害剤としてのアミノチアゾール誘導体
AU2006305769B2 (en) 2005-10-25 2012-06-14 Kalypsys, Inc. Salts of modulators of PPAR and methods of treating metabolic disorders
AU2006326815A1 (en) * 2005-12-20 2007-06-28 Merck Frosst Canada Ltd. Heteroaromatic compounds as inhibitors of stearoyl-coenzyme A delta-9 desaturase
WO2007092435A2 (en) 2006-02-07 2007-08-16 Wyeth 11-beta hsd1 inhibitors
PL2029572T3 (pl) 2006-06-05 2011-05-31 Novartis Ag Związki organiczne
JP2010501567A (ja) 2006-08-24 2010-01-21 ノバルティス アクチエンゲゼルシャフト 代謝系、心血管系および他の障害の処置のためのステアロイル−ＣｏＡ不飽和化酵素（ＳＣＤ）阻害剤としての２−（ピラジン−２−イル）−チアゾールおよび２−（１Ｈ−ピラゾール−３−イル）チアゾール誘導体ならびに関連化合物
AU2007323193A1 (en) * 2006-11-20 2008-05-29 Glenmark Pharmaceuticals S.A. Acetylene derivatives as Stearoyl CoA Desaturase inhibitors
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
US20080176861A1 (en) 2007-01-23 2008-07-24 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
WO2008096746A1 (ja) 2007-02-06 2008-08-14 Takeda Pharmaceutical Company Limited スピロ化合物およびその用途
CA2685266C (en) 2007-04-27 2014-01-28 Purdue Pharma L.P. Trpv1 antagonists and uses thereof for the treatment of prevention of pain, ui and ulcer, ibd, or ibs in an animal
US7842696B2 (en) 2007-06-21 2010-11-30 Forest Laboratories Holdings Limited Piperazine derivatives as inhibitors of stearoyl-CoA desaturase
CA2693169C (en) 2007-07-19 2016-01-12 Metabolex, Inc. N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
ATE488499T1 (de) 2007-08-08 2010-12-15 Graceway Pharmaceuticals Llc Phenoxypyrrolidinderivat, seine verwendung sowie zusammensetzungen daraus
WO2009037542A2 (en) 2007-09-20 2009-03-26 Glenmark Pharmaceuticals, S.A. Spirocyclic compounds as stearoyl coa desaturase inhibitors
BRPI0914891A2 (pt) * 2008-06-20 2015-11-24 Metabolex Inc agonistas de aril gpr119 e usos dos mesmos
EP2398809B1 (en) 2009-02-17 2015-07-08 Merck Canada Inc. Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
EP2459568A4 (en) 2009-07-28 2013-02-27 Merck Frosst Canada Ltd NEW SPIRO COMPOUNDS AS AN INHIBITORS OF STEAROYL COENZYME A DELTA 9 DESATURASE
US20130012709A1 (en) 2009-09-10 2013-01-10 Centre National De La Recherche Scientifique NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES
EP2483281B1 (en) 2009-10-01 2014-06-04 Cymabay Therapeutics, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
CA2802541A1 (en) 2010-06-23 2011-12-29 Metabolex, Inc. Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
PE20141531A1 (es) 2011-06-22 2014-10-23 Purdue Pharma Lp Antagonistas de trpv1 que incluyen sustituyentes dihidroxi y sus usos
US9456998B2 (en) 2012-05-22 2016-10-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Selective inhibitors of undifferentiated cells
CN105596291B (zh) * 2014-11-24 2020-09-08 辽宁海思科制药有限公司 一种磺达肝癸钠注射液组合物
WO2018026890A1 (en) 2016-08-03 2018-02-08 Cymabay Therapeutics Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
MA46589A (fr) 2016-10-24 2019-08-28 Yumanity Therapeutics Inc Composés et utilisations de ces derniers
KR20190108118A (ko) 2017-01-06 2019-09-23 유마니티 테라퓨틱스, 인크. 신경계 장애의 치료를 위한 방법
US11873298B2 (en) 2017-10-24 2024-01-16 Janssen Pharmaceutica Nv Compounds and uses thereof
US11440912B2 (en) 2017-10-27 2022-09-13 Fresenius Kabi Oncology Ltd Process for the preparation of ribociclib and its salts
MX2020009942A (es) 2018-03-23 2021-01-08 Yumanity Therapeutics Inc Compuestos y usos de los mismos.
KR20220007845A (ko) 2019-01-24 2022-01-19 유마니티 테라퓨틱스, 인크. 화합물 및 이의 용도
EA202192047A1 (ru) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. Соединения и их применение

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2319100A (en) * 1999-01-28 2000-08-18 Nippon Shinyaku Co. Ltd. Amide derivatives and drug compositions
ES2209825T3 (es) * 1999-01-29 2004-07-01 Abbott Laboratories Derivados diazabiciclicos utiles como ligandos del receptor nicotinico de la acetilcolina.
US6777414B1 (en) 1999-04-09 2004-08-17 Meiji Seika Kaisha, Ltd. Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
US6677452B1 (en) * 1999-09-30 2004-01-13 Lion Bioscience Ag Pyridine carboxamide or sulfonamide derivatives and combinatorial libraries thereof
JP2003533978A (ja) * 2000-02-24 2003-11-18 ゼノン ジェネティクス，インコーポレイテッド トリグリセリド減少治療薬を同定するステアロイルＣｏＡデサチュラーゼを使用する方法と組成物
GB0013383D0 (en) 2000-06-01 2000-07-26 Glaxo Group Ltd Therapeutic benzamide derivatives
US7160878B2 (en) * 2000-07-27 2007-01-09 Eli Lilly And Company Substituted heterocyclic amides
MY136316A (en) * 2001-02-13 2008-09-30 Sanofi Aventis Deutschland Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical.
EP1383760A1 (en) * 2001-04-30 2004-01-28 Fujisawa Pharmaceutical Co., Ltd. Biarylcarboxamide compounds as apolipoprotein b inhibitors
US6953801B2 (en) * 2001-05-22 2005-10-11 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
JP4186518B2 (ja) * 2001-06-15 2008-11-26 アステラス製薬株式会社 フェニルピリジン誘導体
US7196080B2 (en) * 2001-06-15 2007-03-27 Astellas Pharma Inc. Phenylpyridinecarbonylpiperazinederivative
UY27450A1 (es) * 2001-09-24 2003-04-30 Bayer Corp Preparación y uso de derivados de imidazol para el tratamiento de la obesidad
US20050038035A1 (en) 2001-11-28 2005-02-17 Hisashi Takasugi Heterocyclic amide compounds as apolipoprotein b inhibitors
US20050119251A1 (en) * 2001-12-21 2005-06-02 Jian-Min Fu Nicotinamide derivatives and their use as therapeutic agents
KR20060111716A (ko) * 2002-01-22 2006-10-27 워너-램버트 캄파니 엘엘씨 2-(피리딘-2-일아미노)-피리도[2,3-ｄ]피리미딘-7-온
KR20040094672A (ko) 2002-03-13 2004-11-10 얀센 파마슈티카 엔.브이. 히스톤 디아세틸라제의 신규한 저해제로서의설포닐아미노-유도체
WO2003076400A1 (en) 2002-03-13 2003-09-18 Janssen Pharmaceutica N.V. New inhibitors of histone deacetylase
EP1501827A2 (en) * 2002-04-25 2005-02-02 Pharmacia Corporation Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors
MXPA05007503A (es) * 2003-01-17 2005-09-21 Warner Lambert Co Heterociclicos 2-aminopiridina sustituidos como inhibidores de proliferacion celular.
US20040204422A1 (en) * 2003-04-14 2004-10-14 Abbott Gmbh & Co. Kg. N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
CA2533898A1 (en) 2003-07-29 2005-02-10 Xenon Pharmaceuticals Inc. Pyridyl derivatives and their use as therapeutic agents
AU2004261267B9 (en) * 2003-07-30 2009-04-09 Xenon Pharmaceuticals Inc. Pyridyl derivatives and their use as therapeutic agents
GT200600046A (es) * 2005-02-09 2006-09-25 Terapia de combinacion

Similar Documents

Publication Publication Date Title
JP2007500716A5 (enExample)
JP2007500719A5 (enExample)
JP5608655B2 (ja) Ｐ２ｘ３受容体活性のモジュレーター
JP4833080B2 (ja) １−ピペラジン−および１−ホモピペラジン−カルボキシレートの誘導体、その調製方法、およびｆａａｈ酵素の阻害剤としてのその使用
AU2007318092B2 (en) Calcium receptor modulating agents
JP7175888B2 (ja) 選択的ｈｄａｃ１、２阻害剤としてのピペラジン誘導体
JP2007500715A5 (enExample)
US8853218B2 (en) Compounds
CN103772239B (zh) 酰胺和脒衍生物和其用途
KR20110031318A (ko) Ｉａ 심부전 및 암 치료에 유용한 단백질 키나제 ｄ 억제제로서의 2,4'-비피리디닐 화합물
AU2008263166A1 (en) Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
JP2001502712A (ja) 束縛されたソマトスタチン・アゴニスト及びアンタゴニスト
JP2017537948A (ja) Ｎａｄｐｈオキシダーゼ阻害剤としてのアミドチアジアゾール誘導体
JP2020523330A (ja) シクロプロピルウレアホルミルペプチド２受容体およびホルミルペプチド１受容体アゴニスト
JP2007504120A (ja) アダマンタン誘導体およびアザビシクロオクタン誘導体およびアザビシクロノナン誘導体、ならびにこれらの調製方法およびｄｐｐ−ｉｖ阻害剤としてのこれらの使用
JP2010508288A (ja) キナーゼ阻害剤として有用なヘテロサイクリックアミド化合物
JP2008506744A (ja) α７ニコチン性アセチルコリン受容体の調節物質およびそれらの治療への使用
JP2016505063A (ja) ソルチリン阻害剤としてのｎ置換された５置換フタルアミド酸
KR20180032645A (ko) Ror 감마 조절제로서의 신규한 화합물
JP2007533635A (ja) バニロイド受容体リガンドおよび治療おけるこれらの使用
CN105121415A (zh) Hdac抑制剂
EA018995B1 (ru) Производные карбаматов алкилтиазолов, их получение и их применение в терапии
TW201031638A (en) 4-aryl-butane-1,3-diamides
JP7428833B2 (ja) ヒストン脱アセチル化酵素６阻害剤としての１，３，４－オキサジアゾール誘導体化合物、およびそれを含む医薬組成物
JP2009506127A (ja) 糖尿病の処置に有用なアニリノピラゾール誘導体